EP2547205
Nýjar aðferðir til að miða á krabbameins-stofnfrumur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.3.2011EP published:
20.3.2024EP application number:
11757135.6
EP translation filed:
13.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
20.3.2031Expiry date:
20.3.2026Next due date:
31.3.2026
Title in English:
NOVEL METHODS FOR TARGETING CANCER STEM CELLSLanguage of the patent:
English
Timeline
Today
21.3.2011EP application
20.3.2024EP Publication
13.5.2024Translation submitted
15.6.2024Registration published
20.3.2026Expires
Owner
Name:
1Globe Biomedical Co., Ltd.Address:
8F, Block B, Techart Plaza, No. 30 Xueyuan Road Haidian District, Beijing 100083, CN
Inventor
Name:
LI, Chiang, JiaAddress:
MA 02141, US
Name:
LEGGETT, DavidAddress:
Milton MA 02186, US
Name:
LI, YouzhiAddress:
Westwood MA 02090, US
Name:
LI, WeiAddress:
Wayland MA 01778, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
315886 PDate:
19.3.2010Country:
US
Number:
315890 PDate:
19.3.2010Country:
US
Number:
325814 PDate:
19.4.2010Country:
US
Classification
Categories:
A61K 31/27, A61K 31/343, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 22.4.2024
Expires: 20.3.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 18.3.2025
Expires: 20.3.2026
Payer: Árnason Faktor ehf.